Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Journal of Allergy and Clinical Immunology

Volumn 146, Issue 1, 2020, Pages 110-118

  Li, Xiaochen ^a,b   Xu, Shuyun ^a,b   Yu, Muqing ^a,b   Wang, Ke ^a,b   Tao, Yu ^a,b   Zhou, Ying ^a,b   Shi, Jing ^a,b   Zhou, Min ^a,b   Wu, Bo ^c   Yang, Zhenyu ^a,b   Zhang, Cong ^a,b   Yue, Junqing ^a,b   Zhang, Zhiguo ^a   Renz, Harald ^d   Liu, Xiansheng ^a,b   Xie, Jungang ^a,b   Xie, Min ^a,b   Zhao, Jianping ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING HOSPITAL   (China)

^c China   (China)

^d UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

COVID 19; mortality; risk factors; SARS CoV 2; severity

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LOPINAVIR PLUS RITONAVIR; OSELTAMIVIR; RIBAVIRIN; TUMOR NECROSIS FACTOR; UMIFENOVIR;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGE; AGED; ARTICLE; ASTHMA; BACTEREMIA; CHILD; CHINA; CLINICAL OUTCOME; COHORT ANALYSIS; CORONAVIRUS DISEASE 2019; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEART INJURY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; MORTALITY RISK; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SURVIVAL; BETACORONAVIRUS; COMORBIDITY; COMPLICATION; CORONAVIRUS INFECTION; EPIDEMIOLOGY; MORTALITY; PANDEMIC; TREATMENT OUTCOME; VERY ELDERLY; VIRUS PNEUMONIA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETACORONAVIRUS; CHINA; COHORT STUDIES; COMORBIDITY; CORONAVIRUS INFECTIONS; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85083786720     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2020.04.006     Document Type: Article

References (32)

1. Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395 (2020), 565–574.
2. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Available at: https://www.who.int/csr/sars/country/table2004_04_21/en/ Accessed March 22, 2020.
3. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). Available at: http://www.who.int/emergencies/mers-cov/en/ Accessed March 22, 2020.
4. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. Available at: https://www.who.int/internal-publications-detail/clinical-managementof-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected Accessed March 22, 2020.
5. World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Available at: https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 Accessed March 22, 2020.
6. Metlay, J.P., Waterer, G.W., Long, A.C., Anzueto, A., Brozek, J., Crothers, K., et al. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200 (2019), e45–e67.
7. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506.
8. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print February 24, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2648.
9. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China [published online ahead of print February 28, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032.
10. He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., et al. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol 210 (2006), 288–297.
11. Lam, C.W., Chan, M.H., Wong, C.K., Severe acute respiratory syndrome: clinical and laboratory manifestations. Clin Biochem Rev 25 (2004), 121–132.
12. Sheng, W.H., Chiang, B.L., Chang, S.C., Ho, H.N., Wang, J.T., Chen, Y.C., et al. Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome. J Formos Med Assoc 104 (2005), 715–723.
13. Zhu, M., SARS immunity and vaccination. Cell Mol Immunol 1 (2004), 193–198.
14. Huang, K., Yang, T., Xu, J., Yang, L., Zhao, J., Zhang, X., et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet 394 (2019), 407–418.
15. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [published online ahead of print February 19, 2020]. Allergy. https://doi.org/10.1111/all.14238.
16. Wang, X.D., Zheng, M., Lou, H.F., Wang, C.S., Zhang, Y., Bo, M.Y., et al. An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011. Allergy 71 (2016), 1170–1180.
17. Hashimoto, T., Perlot, T., Rehman, A., Trichereau, J., Ishiguro, H., Paolino, M., et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487 (2012), 477–481.
18. Chai, X., Hu, L., Zhang, Y., Han, W., Lu, Z., Ke, A., et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv, 2020 2020.02.03.931766.
19. Yang, J.K., Lin, S.S., Ji, X.J., Guo, L.M., Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 47 (2010), 193–199.
20. Wu C, Chen X, Cai Y, Xia Ja, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [published online ahead of print March 13, 2020]. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994.
21. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis [published online ahead of print March 26, 2020]. Eur Respir J. https://doi.org/10.1183/13993003.00547-2020.
22. Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436 (2005), 112–116.
23. Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11 (2005), 875–879.
24. Crackower, M.A., Sarao, R., Oudit, G.Y., Yagil, C., Kozieradzki, I., Scanga, S.E., et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417 (2002), 822–828.
25. Erez, A., Shental, O., Tchebiner, J.Z., Laufer-Perl, M., Wasserman, A., Sella, T., et al. Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients. Isr Med Assoc J 16 (2014), 439–443.
26. Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395 (2020), 1054–1062.
27. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published online ahead of print February 24, 2020]. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30079-5.
28. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [published online ahead of print March 18, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2001282.
29. Chan, J.F., Yuan, S., Kok, K.H., To, K.K., Chu, H., Yang, J., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395 (2020), 514–523.
30. Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 382 (2020), 970–971.
31. Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19 [published online ahead of print February 27, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2783.
32. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? [published online ahead of print February 22, 2020] Int J Epidemiol. https://doi.org/10.1093/ije/dyaa033.